| New Vision Behavioral Health Inc | |
|
1601 49th St S Gulfport FL 33707-4340 | |
| (727) 687-0997 | |
| Not Available |
| Full Name | New Vision Behavioral Health Inc |
|---|---|
| Speciality | Community/behavioral Health |
| Location | 1601 49th St S, Gulfport, Florida |
| Authorized Official Name and Position | Zaneta Ellison (OWNER/THERAPIST) |
| Authorized Official Contact | 7274007643 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| New Vision Behavioral Health Inc Po Box 11913 Saint Petersburg FL 33733-1913 Ph: (727) 687-0997 | New Vision Behavioral Health Inc 1601 49th St S Gulfport FL 33707-4340 Ph: (727) 687-0997 |
| NPI Number | 1497291041 |
|---|---|
| Provider Enumeration Date | 01/06/2017 |
| Last Update Date | 09/17/2021 |
| Certification Date | 09/02/2021 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497291041 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | MH12585 (Florida) | Primary |
News Archive
Concerns about the use of letrozole, an easy-to-use and inexpensive drug for the treatment of infertility, appear to be unfounded, according to a major study co-authored by Dr. Togas Tulandi, Director of Division of Reproductive Endocrinology and Infertility, McGill University Health Centre (MUHC) and Chief of Obstetrics and Gynecology at the Jewish General Hospital, and Professor of Obstetrics and Gynecology at McGill University.
Sangamo BioSciences, Inc., a leader in therapeutic genome editing, announced today that the company and its collaborator, Shire plc, have agreed to revise their January 2012 collaboration and license agreement to expedite the development of ZFP Therapeutics for hemophilia A and B and Huntington's disease.
HealthLeaders-InterStudy and Fingertip Formulary find that 70 percent of surveyed pharmacy directors expect to cover Pfizer's tanezumab if it is approved for the treatment of chronic pain. Tanezumab, which is expected to be the first biologic approved for chronic pain and is administered intravenously under medical supervision, will likely be covered as a medical benefit rather than a pharmacy benefit according to surveyed pharmacy directors.
Cutting levels of household allergens, such as cat dander and dust mite, is unlikely to have much impact on the subsequent development of childhood asthma and respiratory allergies, suggests research in Thorax.
› Verified 7 days ago
Center For Human Potential, P.a. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 5301 Gulfport Blvd S, Gulfport, FL 33707 Phone: 727-894-9777 Fax: 727-202-1010 | |
Dr. Katie Schubert, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6132 8th Ave S, Gulfport, FL 33707 Phone: 209-482-8567 |